{'fraction_non_alphanumeric': 0.02086230876216968, 'fraction_numerical': 0.017385257301808066, 'mean_word_length': 5.918269230769231, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Preliminary Canadian Environmental Emissions Inventory for Endogenous and Retail Pharmaceutical Estrogens

ABSTRACT Pharmaceuticals and personal care products (PPCPs), including estrogen pharmaceuticals, have been an environmental concern for well more than a decade, but no environmental emissions inventory for Canada has yet been published. Endogenous estrogens cannot be distinguished from the equivalent pharmaceutical estrogens in the environment. Therefore, data were compiled to estimate total environmental emissions of endogenous and retail pharmaceutical estrogens by the Canadian population for year 2007. Approximately 1,700 kg of pharmaceutical estrogens were dispensed through retail pharmacies in Canada in 2007. Of this amount, total environmental emissions were estimated to be approximately 730 kg, half to surface water via municipal sewage outfalls (> 90% via sewage treatment plants providing primary, secondary, or tertiary treatment), and half to the soil vadose zone and (potentially) groundwater via in situ sewage treatment systems. Approximately 960 kg of endogenous estrogens were excreted by the Canadian population, with about 420 kg reaching the environment, again approximately half to each of surface water and soil/groundwater. In situ sewage treatment may deliver an equivalent load of estrogens to the environment as do sewage treatment plants, despite servicing only 22% of the Canadian population.